Antibody formulation

Disclosed is a pharmaceutical formulation comprising an antibody that binds to VEGF in an arginine acetate buffer at a pH from about 4.5 to about 6.0, and a surfactant, wherein the antibody is bevacizumab.

Saved in:
Bibliographic Details
Main Authors LI MEGAN, LIU HONG, CROMWELL MARY, KAMERZELL TIMOTHY J, GOKARN YATIN R
Format Patent
LanguageEnglish
Published 27.05.2016
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a pharmaceutical formulation comprising an antibody that binds to VEGF in an arginine acetate buffer at a pH from about 4.5 to about 6.0, and a surfactant, wherein the antibody is bevacizumab.
Bibliography:Application Number: NZ20100700111